| Term 
 
        | What are the four pathways were we see dopamine? Where are they running and what do they do? |  | Definition 
 
        | 1. **Nigrostriatal tract; from substantia nigra to the striatum [MOVEMENT] -Loss of DA neurons here leads to the excess action of ACh on GABA-ergic neurons and extrapyramidal dysfunction seen in Parkinson Disease
 -Antagonists-->pseudo-Parkinsonism
 -Agonist-->(hypokinetic) dyskinesias
 
 2. Mesolimbic-mesocortical tracts; in midbrain and projects to frontal cortex and limbic structures [MOOD]
 -Agonist-->pleasure and desire to repeat (reinforcement); drug addiction and psychosis (the repetitive behaviors of)
 -Also deals with perception of sensory stimuli & affect
 -Antagonists-->decreased cognitive function
 
 3. Tuberoinfundibular tract; cell bodies from hypothalamus to the anterior pituitary to lower *prolactin (milk secretion)
 -Agonists-->for hyperprolactinemic states (pit. tumor)
 -Antagonists-->cause endocrine dysfunction (gynecomastia or milk production)
 -Also inhibits GH (acromegaly without), regulates temp. (get hot without), and inhibits appetite (get fat without)
 
 4. Chemoreceptor trigger zone; vomiting
 -Common side effect & can antagonize for chemo patients
 |  | 
        |  | 
        
        | Term 
 
        | What are the types of dopamine receptors? What are the two most important ones? |  | Definition 
 
        | -D1 & D2 types 
 -D2a; nigrostriatal-->movement
 -D2c; mesolimbic--> mood (better target for antipsychotics-->Clozapine; but rest are non selective)
 |  | 
        |  | 
        
        | Term 
 
        | What is Parkinson disease? When do we see it? What are the symptoms? |  | Definition 
 
        | -In about 2% of the pop. over 70; from oxidative injury to dopamine neurons in *nigrostriatum (non-familial) 
 Pathology;
 -Too little DA and too much ACh
 
 **Triad of symptoms;
 -Bradykinesia; slow onset of movement, gives shuffling
 -Muscle rigidity
 -Resting tremor
 |  | 
        |  | 
        
        | Term 
 
        | What are four strategies we could use for Parkinson's? |  | Definition 
 
        | 1. L-DOPA-->increases DA synth 2. DA receptor agonist
 3. M receptor antagonist (atropine and others)
 4. Selegiline-->inhibits MAO-B
 
 -Reference page 161
 |  | 
        |  | 
        
        | Term 
 
        | What is levodopa? What is it given with? Side effects? |  | Definition 
 
        | -It is taken up in the brain and converted to dopamine -**Carbidopa is given with it and inhibits *peripheral metabolism by AAAD (aromatic amino acid decarboxylase); converts L-dopa to dopamine
 -Carbidopa doesn't cross BBB (need conversion in CNS)
 
 Side effects;
 -Dyskinesias with "on-off" effects; from fluctuations
 -Psychosis; from mesolimbic/cortical tracts
 -Vomiting; from chemoreceptor trigger zone
 -HypOtension; from periphery action in ANS
 
 -Maybe some weight loss as well
 |  | 
        |  | 
        
        | Term 
 
        | How do we inhibit COMT? What does it do? |  | Definition 
 
        | -Tolcapone and entacapone (-capones; Al Capone gets comped everywhere he goes lol) -Tolcapone is hepatotoxic
 -Crosses BBB (must inhibit there and periph)
 
 -COMT converts DA and L-dopa to 3-O-methyldopa in the periphery *and in the CNS; acts as partial agonist
 -D receptors are blocked, and uptake is lowered
 |  | 
        |  | 
        
        | Term 
 
        | How do we inhibit MAOb? What does it do? Side effects |  | Definition 
 
        | -*Selegiline -It is very **selective for MAOb so we see no tyramine interactions (MAOa inh. + tyramine [releaser] gives *hypertensive crisis)
 
 -MAOb metabolizes DA in the neurons
 
 -Still get dyskinesias and psychosis (from two main tracts)
 -Also get *insomnia b/c selegeline is metabolized to *amphetamine (a psychostimulant)
 
 -Think of a cat named Geline who's on amphetamine and goes MAOoOoOoOO!... so we want to sell her haha.
 |  | 
        |  | 
        
        | Term 
 
        | What are some dopamine-receptor agonist? What do they treat? |  | Definition 
 
        | *Bromocriptine & pergolide -For hyperprolactinemia and acromegaly (both from tuberoinfundibular tract)
 -*Dyskinesias and psychosis* is too much with direct antagonism for Parkinson's use
 
 *Pramipexole & *ropinirole
 -Can be used for Parkinson's and are also *antioxidants
 
 -BP PR
 |  | 
        |  | 
        
        | Term 
 
        | What are the antimuscarinics we use for Parkinson disease? Side effects? |  | Definition 
 
        | -Benztropine & trihexyphenidyl; already learned (atropine-like) 
 -*Diphenhydramine; an antihistamine (**all antihistamines are potent anti-muscarinic drugs)
 -Often for acute attacks (from over blockage of DA when treating psychosis)
 
 Side effects; (All M block related)
 -Dry mouth (low secretions)
 -Blurred vision (no accommodation)
 -Mydriasis (SANS takes over)-->glaucoma maybe
 -Urinary and fecal retention
 -Three Cs (cardiotoxicity, convulsions, coma)
 |  | 
        |  | 
        
        | Term 
 
        | What is amantadine? Side effect? |  | Definition 
 
        | Antiviral medication that also; -Is an *M-blocker
 -*Increases dopamine release
 
 Side effects;
 -Atropine-like
 -***Livedo reticularis (only one that will do this); swollen venules that gives reddish-purple spiderweb appearance
 |  | 
        |  | 
        
        | Term 
 
        | What is the theory and treatment strategy for psychosis? |  | Definition 
 
        | -↑DA→positive symptoms (hallucinations, delusions, etc.) -↓5HT→negative symptoms (social withdraw, etc.)
 -Came up with this because DA agonist can cause psychosis, and antagonist can treat psychosis
 
 -Strategy then is **block DA and **↑5HT (with **5HT2 receptors**; do neg. feedback similar to α2)
 |  | 
        |  | 
        
        | Term 
 
        | What is the difference b/t typical and atypical antipsychotics? |  | Definition 
 
        | -Typical antagonize DA receptors -Atypical do other things
 |  | 
        |  | 
        
        | Term 
 
        | What is the special DA blocker for Tourette syndrome? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What do we expect as side effects to antipsychotics? |  | Definition 
 
        | DA blockade; 1. Dyskinesias (called extrapyramidal symptoms; **EPS)
 -Progresses from acute to chronic (**Tardive dyskinesia)
 -Treat initially with anti-Ms, but chronic is irreversible
 2. Dysphoria (disruption of reward pathway)
 3. Endocrine dysfunction (*temp, prolactin, & eating)
 
 Muscarinic blockade; tachycardia and ↓seizure threshold
 Alpha blockade; hypotension (w/ reflex tachy)
 -These two are just accidental blockades
 
 -Check **163 for full info (esp. for EPSs)
 |  | 
        |  | 
        
        | Term 
 
        | Specifically, what is the temp problem associated with DA blockade and how do we treat? Drug most likely to cause? |  | Definition 
 
        | -**Neuroleptic malignant syndrome (NMS); very similar to malignant hyperthermia caused by succinylcholine (depolarizing muscle relaxant) 
 -Treatment; Bromocriptine (DA agonist) and dantrolene (blocks Ca2+ channels in SR)
 
 -Haloperidol or fluphenazine are most likely (little M-blocking activity)
 |  | 
        |  | 
        
        | Term 
 
        | What is the main advantage to the atypical drugs? What is a strange effect of 5HT2 antagonism? |  | Definition 
 
        | -Less EPS -Wet pillow syndrome (increased salvation)
 |  | 
        |  | 
        
        | Term 
 
        | Go through the drug list on pg. 164. |  | Definition 
 | 
        |  |